Merck

Merck & Co. buying SmartCells for $500 million
Marketwatch
Thu, 12/2/10 - 09:20 am
SmartCells
M&A
Merck
diabetes
Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wed, 12/1/10 - 05:55 pm
Merck
Proscar
FDA
prostate cancer
Incoming Merck chief to focus on pricing
FT.com
Wed, 12/1/10 - 07:18 am
Merck
Pharma CEOs
pricing
Kenneth Frazier
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Drug groups face new generics threat
FT.com
Tue, 11/30/10 - 10:57 am
generics
Roche
Merck
JNJ
Abbott Laboratories
biogenerics
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
RNAi
Merck
Alnylam
Pfizer
Amgen
Novartis
Eli Lilly
Roche
Merck Names Kenneth Frazier CEO, Clark Stays as Chairman
Bloomberg
Tue, 11/30/10 - 09:15 am
Merck
Pharma CEOs
Kenneth Frazier
Drug groups face new generics threat
FT.com
Mon, 11/29/10 - 02:50 pm
generics
Roche
Merck
JNJ
Abbott Laboratories
GSK
AstraZeneca
Teva Pharmaceuticals
Hospira
Novartis
An Innovator’s Dilemma For Merck AIDS Drug
Forbes
Mon, 11/29/10 - 11:24 am
Merck
HIV
AIDS
Isentress
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Bloomberg
Sat, 11/27/10 - 01:17 pm
Merck
Pfizer
CETP inhibitors
Is Merck the Perfect Stock?
Motley Fool
Wed, 11/24/10 - 08:34 am
Merck
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tue, 11/23/10 - 09:27 am
endometrial cancer
Ariad Pharmaceuticals
Merck
mTOR inhibitors
ridaforolimus
Let's Call It a Partial Victory (Merck)
Motley Fool
Tue, 11/23/10 - 08:57 am
Merck
Vytorin
kidney disease
Genzyme ($GENZ) proffers milestone-based deal to potential suitors
Fierce Biotech
Mon, 11/22/10 - 12:43 pm
Genzyme
milestone payments
Sanofi
M&A
Pfizer
Merck
JNJ
Merck, Vytorin & Questionable Oxford Researchers
Pharmalot
Mon, 11/22/10 - 12:39 pm
Merck
Vytorin
Merck Wins Third Fosamax Trial; Record Now Stands at 2-1
WSJ Online
Mon, 11/22/10 - 10:41 am
Merck
Fosamax
lawsuits
Merck Cholesterol Drug Is Found to Help Kidney Patients
WSJ Online
Mon, 11/22/10 - 10:23 am
Merck
Vytorin
kidney disease
VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study
MarketWatch
Sat, 11/20/10 - 01:35 pm
Vytorin
Merck
chronic kidney disease
Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial
Yahoo/BusinessWire
Sat, 11/20/10 - 12:41 pm
Merck
Fosamax
lawsuits
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Sat, 11/20/10 - 12:20 pm
Merck
CETP inhibitors
Anacetrapib
cholesterol

Pages